Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z5VQ
|
||||
Former ID |
DNCL001899
|
||||
Drug Name |
Terutroban sodium
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Thromboembolism [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Discontinued in Phase 3 | [546968] | ||
Company |
Servier
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H21ClNNaO4S
|
||||
Canonical SMILES |
CC1=C(C2=C(CC(CC2)NS(=O)(=O)C3=CC=C(C=C3)Cl)C=C1)CCC(=O<br />)[O-].[Na+]
|
||||
InChI |
1S/C20H22ClNO4S.Na/c1-13-2-3-14-12-16(6-9-19(14)18(13)10-11-20(23)24)22-27(25,26)17-7-4-15(21)5-8-17;/h2-5,7-8,16,22H,6,9-12H2,1H3,(H,23,24);/q;+1/p-1/t16-;/m1./s1
|
||||
InChIKey |
BQMSKINGUUUIHE-PKLMIRHRSA-M
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Thromboxane A2 receptor | Target Info | Antagonist | [528120] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.